July 8, 2021

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science Read More »

September 10, 2020

ProSciento Closes Growth Financing from 1315 Capital Read More »


View Recent Webinar


July 1, 2021

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study. Read More »

June 25, 2021

Poster Presentations: American Diabetes Association 81st Scientific Sessions 2021 Read More »

February 3, 2021

Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Read More »

Stay Connected

Would you like to receive updates from ProSciento?